Efficacy of Ultrasound Contrast Agent to Assess Renal Masses

PHASE2CompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

October 31, 2012

Study Completion Date

December 31, 2012

Conditions
Renal Cell Carcinoma
Interventions
DRUG

Definity

Definity is the contrast agent which is going to be injected in a bolus and infusion forms during the ultrasound performance.

Trial Locations (1)

M5G 2C4

Toronto General Hospital, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Lantheus Medical Imaging

INDUSTRY

lead

University Health Network, Toronto

OTHER